GANX
Gain Therapeutics, Inc.
$1.87-0.08 (-4.10%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Gain Therapeutics, Inc. (GANX) is a publicly traded company with 2 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 2 unique insiders. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
9 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-27 | 2026-03-24 | Mack Gene | CEO | Award | 200,000 | $1.86 | $372,000 | N/A | N/A |
| 2026-03-27 | 2026-03-24 | Fuggetta Gianluca | See Remark | Award | 50,000 | $1.86 | $93,000 | N/A | N/A |
| 2025-06-25 | 2025-06-24 | Melincoff Gwen A | Director | Award | 15,000 | $0.00 | $0 | N/A | N/A |
| 2025-06-25 | 2025-06-24 | Nicaise Claude | Director | Award | 15,000 | $0.00 | $0 | N/A | N/A |
| 2025-06-25 | 2025-06-24 | Richman Eric I | Director | Award | 15,000 | $0.00 | $0 | N/A | N/A |
| 2025-06-25 | 2025-06-24 | Riley Jeffrey Scott | Director | Award | 15,000 | $0.00 | $0 | N/A | N/A |
| 2025-06-25 | 2025-06-24 | Hasler Hans Peter | Director | Award | 15,000 | $0.00 | $0 | N/A | N/A |
| 2025-06-25 | 2025-06-24 | Islam Khalid | Director | Award | 15,000 | $0.00 | $0 | N/A | N/A |
| 2025-06-25 | 2025-06-24 | Goldstein Dov A Md | Director | Award | 15,000 | $0.00 | $0 | N/A | N/A |